Short answer: Both are prescription retinoids for acne used once in the evening, but tazarotene (Tazorac) is also approved for psoriasis and is not allowed in pregnancy.12 In a 12-week trial of 143 people, tazarotene 0.1% gel cleared non-inflamed spots better than tretinoin 0.025% gel.3 A later trial of other strengths found results generally similar.4
| Tretinoin (Retin-A) | Tazarotene (Tazorac cream) | |
|---|---|---|
| Approved for | Acne1 | Plaque psoriasis (0.05% and 0.1%); acne (0.1%)2 |
| Strengths on these labels | Cream 0.025%, 0.05%, 0.1%; gel 0.01%, 0.025%1 | Cream 0.05% and 0.1%2 |
| Directions | Once a day before bed, enough to cover the area lightly1 | Thin layer once a day in the evening, only on affected skin2 |
| When results show (acne) | After 2 to 3 weeks; more than 6 weeks may be needed1 | Not stated in the sections checked |
| Pregnancy | Use only if the benefit justifies the risk1 | Contraindicated; negative pregnancy test within 2 weeks before starting and birth control during use2 |
| Common side effects | Redness, swelling, blistering or crusting in sensitive skin1 | Acne: peeling, dry skin, redness, burning in 10% to 30%2 |
| Blood levels | Not given on the label | Tazarotenic acid half-life about 18 hours2 |
| Head-to-head trials | Tretinoin 0.025% gel; tretinoin 0.04% microsphere gel34 | Tazarotene 0.1% gel did better on non-inflamed spots; 0.05% cream was generally similar to the microsphere gel34 |
The trials used different strengths and forms, so neither settles which retinoid suits a given person.
The Tazorac label says tazarotene can harm a fetus and is contraindicated in pregnancy. Women who could become pregnant need a negative pregnancy test within 2 weeks before starting and effective birth control during treatment.2 The Retin-A label says tretinoin should be used in pregnancy only if the benefit justifies the risk.1
More detail: the Tretinoin and Tazarotene guides.